Literature DB >> 8327544

Chronic and acute tolerance to subjective effects of nicotine.

K A Perkins1, J E Grobe, L H Epstein, A Caggiula, R L Stiller, R G Jacob.   

Abstract

Tolerance to subjective effects of nicotine may induce novice smokers to increase the magnitude and frequency of their nicotine self-dosing. In this study, smokers (n = 8) and nonsmokers (n = 7) participated in three sessions involving presentation of 0, 7.5, or 15 micrograms/kg nicotine 30 min for 2 h via measured-dose nasal spray, with different doses presented on separate days. Subjective responses were assessed using visual analog scales (VASs) of jittery, light-headed, relaxed, dizzy, and head rush, and the Profile of Mood States (POMS) scales of vigor, confusion, fatigue, tension, and the composite scale of arousal. Smaller responses in smokers vs. nonsmokers were viewed as evidence for chronic tolerance. In addition, on each day subjects received a fifth, challenge dose of 30 micrograms/kg 30 min after the previous dosing. Smaller responses to the challenge dose as a function of increasing prior nicotine dosing during Trials 1-4 were viewed as evidence for acute tolerance. Results showed significant changes in most measures as a function of nicotine dose, and the dose-response curves for most VAS and POMS scales tended to be shifted to the right, or dampened, in smokers relative to nonsmokers, consistent with chronic tolerance. However, smokers and nonsmokers tended to respond to nicotine in opposite directions for POMS scales of vigor and arousal, perhaps reflecting withdrawal relief in smokers. Acute tolerance on a few selected VAS and POMS scales was apparent for both smokers and nonsmokers.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8327544     DOI: 10.1016/0091-3057(93)90254-q

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  16 in total

1.  Blowing smoke: how cigarette manufacturers argued that nicotine is not addictive.

Authors:  J Sharfstein
Journal:  Tob Control       Date:  1999       Impact factor: 7.552

Review 2.  Nicotine and networks: Potential for enhancement of mood and cognition in late-life depression.

Authors:  Jason A Gandelman; Paul Newhouse; Warren D Taylor
Journal:  Neurosci Biobehav Rev       Date:  2017-08-30       Impact factor: 8.989

Review 3.  The addictive role of nicotine in tobacco use.

Authors:  J E Henningfield; S J Heishman
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

4.  Desensitization of the nicotine-induced mesolimbic dopamine responses during constant infusion with nicotine.

Authors:  M E Benwell; D J Balfour; C E Birrell
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

5.  Acute nicotine-induced tachyphylaxis is differentially manifest in the limbic system.

Authors:  Yantao Zuo; Hanbing Lu; D Bruce Vaupel; Yi Zhang; Svetlana I Chefer; William R Rea; Anna V Moore; Yihong Yang; Elliot A Stein
Journal:  Neuropsychopharmacology       Date:  2011-07-27       Impact factor: 7.853

6.  Nicotine discrimination in male and female smokers.

Authors:  K A Perkins; A DiMarco; J E Grobe; A Scierka; R L Stiller
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

7.  Acute tolerance to nicotine in smokers: lack of dissipation within 2 hours.

Authors:  K A Perkins; J E Grobe; S L Mitchell; J Goettler; A Caggiula; R L Stiller; A Scierka
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

Review 8.  Hormones, nicotine, and cocaine: clinical studies.

Authors:  Nancy K Mello
Journal:  Horm Behav       Date:  2009-10-14       Impact factor: 3.587

9.  Alcohol-induced increases in smoking behavior for nicotinized and denicotinized cigarettes in men and women.

Authors:  Andrea King; Patrick McNamara; Megan Conrad; Dingcai Cao
Journal:  Psychopharmacology (Berl)       Date:  2009-11       Impact factor: 4.530

Review 10.  Individual variability in responses to nicotine.

Authors:  K A Perkins
Journal:  Behav Genet       Date:  1995-03       Impact factor: 2.805

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.